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ABSTRACT 
Background: That risk factors measured in middle-age may not fully explain future dementia 
risk implicates exposures acting earlier in life.  
Aims: Height may capture early life illness, adversity, nutrition, and psychosocial stress. We 
investigated the little-explored association between height and dementia death. 
Method: Individual-participant meta-analysis using eighteen prospective general population 
cohort studies with identical methodologies (baseline 1994-2008; N=181,800). 
Results: Mean follow-up of 9.8 years gave rise to 426 and 667 dementia deaths in men and 
women, respectively. Mean(SD) height for men was 174(7.3)cm, and 161.0(6.8)cm for women. 
In analyses taking into account multiple covariates, increasing height was related to lower rates of 
death from dementia in a dose-response pattern (ptrend≤0.01). There was evidence of a 
differential effect by gender (pinteraction=0.016). Thus, the association observed in men (hazard 
ratio per SD decrease in height; 95%CI: 1.24;1.11-1.39) was markedly stronger than that 
apparent in women (1.13;1.03-1.24).  
Conclusions: Early life circumstances, indexed by adult height, may influence later dementia 
risk. 
Declaration of Interest: none 
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INTRODUCTION 
With no current disease-modifying treatments for dementia, there is a pressing need to 
understand the aetiology of this condition with a view to delaying or preventing its onset. It is 
evident that known risk factors for dementia measured in middle-age – hypertension, smoking, 
obesity, and dyslipidaemia – do not seem to fully explain the occurrence of the disease.1-3 This 
has prompted some recent interest in the pre-adult origins of dementia.4  
 
In the absence of cohort studies beginning in childhood with a sufficiently long period of follow 
up to allow enough individuals to develop dementia in later life, investigators have relied on the 
distant recall of early life risk factors, such as early parental death and childhood socioeconomic 
adversity.5-7 This raises concern regarding reporting bias.8 Height may be more useful in this 
context. It is regarded as a marker of early life illness, adversity, nutrition and psychosocial 
stress,9 environmental characteristics that influence brain development which may then impact 
upon dementia risk.10 Importantly, while there may be some loss of height in late life, it remains 
relatively stable from early to late adulthood and may therefore be a reliable marker of early life 
exposures.  
 
Findings from a small series of cohort studies indicate that lower physical stature is associated 
with elevated rates of dementia11 and this effect may be different in men and women.12 However, 
in general, studies have been underpowered. The fact that the few extant studies are small in 
scale hampers a detailed examination of the height-dementia association in detail, for example, in 
exploring threshold effects and planned sub-group analyses of the height-dementia relationship, 
including by gender.  
 
Accordingly, in this study, we add to the limited evidence base by presenting an individual 
participant meta-analysis of eighteen large, prospective, general population-based, cohort studies. 
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Individual participant meta-analysis has several advantages relative to the more commonly used 
literature-based approach, including: the inclusion of unpublished data so minimising publication 
bias; a more precise estimate of associations between risk marker and disease than in lesser-
powered single studies; reliable information on the ‘shape’ of the association; and a consistent 
approach to statistical control for plausible covariates. To the best of our knowledge, this is the 
largest study to date to examine the association between height and dementia and the first 
individual participant meta-analysis on the topic. 
 
METHODS 
Study samples 
Participants were taken from the Health Survey for England13 (1994-2008) and the Scottish 
Health Survey14 (1995, 1998, and 2003), both representative, general population-based health 
examination studies sampling individuals living in households in the UK. From 1994-2008, 
eighteen independent, cross-sectional studies with almost identical methodologies were 
conducted either on an annual (HSE) or occasional (SHS) basis. The majority of study members 
(88.3%) consented to mortality surveillance by linkage to the UK National Health Service death 
register. The near identical nature of these surveys, allied with this recent retrospective and 
prospective linkage of study members to mortality records, makes possible a unique individual 
participant meta-analysis. Study participants gave full informed consent and ethical approval for 
data collection was granted by the London Research Ethics Council or the Local Research Ethics 
Councils. 
 
Participants were visited by a trained interviewer, who measured height and weight, and 
subsequently by a nurse, who collected biomedical data. The interviewer measured height once 
with shoes removed (to the nearest millimetre) with the informant stretching to their maximum 
height. The head was positioned in the Frankfort plane and a portable stadiometer with a sliding 
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plate, a base plate and three connecting rods marked with a metric measuring scale was used. 
Weight was measured using electronic digital scales and, with height, allowed computation of 
body mass index using the usual formula (weight[kg]/(height[m])2).  
 
Information on occupational social class was collected during the interview and coded according 
to the Registrar General classification (professional, intermediate, skilled non-manual, skilled 
manual, part-skilled, and unskilled), a standard approach in the UK.15 Age upon leaving full-time 
education was recorded as <15, 15, 16, 17, 18, >18 years, ‘never went to school’, and ‘still in full-
time education’. Ethnic group was based on self-report. Smoking status was classified as never a 
regular smoker, ex-smoker, and smoker with daily consumption recorded. During the interview, 
participants were asked whether or not they suffer from a long-standing illness. At the nurse 
visit, systolic blood pressure was measured with the mean of the second and third readings used 
in the present analyses. Blood was drawn to measure serum cholesterol. 
 
Ascertainment of Dementia 
Causes of death (up to ten) recorded on certificates were coded using the International 
Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10) revisions. Any mention of 
dementia death was identified using codes 290.0 to 290.4, 294.9, 331.0 to 331.2, and 331.9 for 
ICD-9 and F00, F01, F03, F09, G30 and G31 for ICD-10. In preliminary analyses we examined 
the impact of using broad (any mention of dementia) and narrow definitions of dementia (where 
dementia was the underlying cause of death). Since results were essentially the same but the 
broader definition resulted in greater power (Supplementary Table 1) we used any mention of 
dementia in all survival analyses. 
 
Dose-response meta-analysis 
6 
 
After ascertaining that the proportional hazards assumption had not been violated we used Cox 
proportional hazards models16 to compute study-specific hazard ratios with accompanying 95% 
confidence intervals for the association between height and dementia death. We report hazard 
ratios for height quartiles with the tallest group as the referent. With preliminary analyses 
revealing that the height-dementia association was linear, we also report hazard ratios per one 
standard deviation (SD) reduction in height (one SD = 6.8cm in women; 7.3cm in men).  
 
Heterogeneity in the effect estimates between studies was examined using the I2 statistic, which 
indicates the proportion of the total variation in the estimates that is due to between-studies 
variation. Preliminary analyses revealed that the I2 statistic ranged between 0 and 58% so we 
pooled the study-specific effect estimates and their standard errors in random effects meta-
analyses, an approach we have taken in previous analyses.15, 17, 18 Calendar time (months) from 
survey date was the underlying time scale; for participants who did not die from dementia, data 
were censored at the end of March 2011.  
 
Data for men and women were analysed separately. Models were initially adjusted for age and 
then additionally for a series of covariates: occupational social class, educational attainment, 
ethnic group, body mass index, smoking status, and self-reported longstanding illness. We also 
controlled for birth year to allow for secular increases in height.19 Data for blood pressure and 
serum cholesterol were not collected in every survey (see Supplementary Table 2) and were 
additionally missing for some participants during the survey years when data collection took 
place; these data therefore only feature in subgroup analyses. We compared the effects of 
controlling for different confounding and mediating variables on the magnitude of the 
association by examining the change in hazard ratio rather than a change in significance level.20 
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Individuals with data missing for one or more variable and those with no missing data were 
compared using Student’s t-test for continuous variables and 2 tests for categorical variables. All 
analyses were conducted using R version 3.0.2. The reporting of our analyses conforms to the 
STROBE statement.21 
 
RESULTS 
Figure 1 shows the derivation of the analytical sample. Excluding 1840 individuals missing 
consent data and 1365 missing survival time reduced the sample size from 222,829 to 219,624. 
With other exclusions (survey participants who declined mortality follow up or whose height was 
not measured), the final analytic sample was 181,800 (55% female; mean[SD] age at baseline 
45.0[18.0]; among those who died mean[SD] age at death 55.8[17.5]). Further details of the 
individual cohort studies and individuals who did and did not consent to mortality follow up are 
provided in Supplementary Tables 2 and 3 respectively.  
 
Baseline characteristics of the sample by height quartile are shown in Table 1. Increasing height 
was generally associated with a more favourable risk factor profile in both sexes: taller study 
members were younger, from higher socioeconomic backgrounds, more likely to be white 
British, had slightly lower body mass index, a lower prevalence of longstanding illness, and lower 
levels of blood pressure and serum cholesterol. Taller men were also less likely to smoke but the 
reverse was true of women. 
 
Of the 17,553 deaths recorded during a mean(SD) follow up of 9.8(4.4) years, 1093 were 
dementia-related. Figure 2 shows the age-adjusted hazard ratios for the association between one 
SD decrease in height and dementia death in men and women for each cohort study. Overall, 
there was a 26% increased risk of dementia death per SD decrease in height in men (HR 1.26; 
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95%CI 1.14-1.40; Ptrend<0.001) and 10% increased risk of dementia death in women (1.10; 1.01-
1.19; Ptrend=0.031). 
 
Table 2 shows the association between height quartile and dementia death after adjustment for 
covariables. In age-adjusted analyses, there was a dose-response association in both men and 
women such that lower physical stature was associated with raised dementia mortality rates. 
There was also some evidence of weaker associations in women than men: a formal test for 
effect modification was statistically significant at conventional levels (Multivariable adjusted 
model: Pinteraction=0.016). Adjusting for measures of socioeconomic status had a modest 
attenuating effect on this association. 
 
Sensitivity and sub-group analyses 
We conducted a series of sensitivity and sub-group analyses to test the robustness of our results. 
Data were missing for one or more variable in 34,833 individuals (18.0%). Individuals with 
complete data for all variables are compared to those with any missing data in Supplementary 
Table 4. While there were some differences in study characteristics, when we computed age-
adjusted hazard ratios using a non-missing sample, it replicated the main findings. Additionally, 
dropping deaths occurring in the first five years of follow-up to explore reverse causality did not 
alter our conclusions (Table 2). 
 
DISCUSSION 
The main findings of this study are a dose-response association between shorter height and risk 
of subsequent dementia death. There was some suggestion that this relationship was stronger in 
men. It was robust to adjustment for a series of covariates including socioeconomic status and 
extant illness. That we were also able to demonstrate known associations between shorter stature 
and an increased risk of cardiovascular disease22, 23 (age- and sex-adjusted HR per SD decrease in 
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height 1.11; 95%CI 1.07-1.16) but a decreased risk of cancer24 (0.94; 0.89-0.98) in this meta-
analysis gives us confidence in the more novel height-dementia association.  
 
Mechanisms of effect 
The fact that the observed association between height and dementia was apparently robust to the 
adjustment of a series of covariables leads to speculation regarding the mechanisms which might 
generate this relationship. Clearly height in itself is not a risk factor for dementia; rather, the 
exposures it captures may be key. In addition to genetic factors, a recent review of 
epidemiological studies highlighted various socio-environmental determinants of adult height, 
including early life socioeconomic circumstances, childhood nutrition, chronic psychosocial 
stress, and chronic illness.19 Insulin growth factor IGF-1 has been linked to cerebral amyloid25 
and, similarly, growth hormone levels, which are correlated with height and also linked to 
hippocampal function and cognition. Thus, IGF-1 might play a role in the association between 
height and dementia death.4 Furthermore, important exposures may also act in utero, but research 
linking birth characteristics to dementia is sparse. 
 
There is also the possibility that height might be a measure of cognitive and functional reserve26 
and a positive association has been demonstrated between height and intelligence,27 which is also 
related to dementia risk, particularly vascular dementia.10, 28 A further possibility is a common 
genotype determining height and dementia risk.  
 
Average height in populations has generally increased in a secular fashion over the last hundred 
years, with a particularly marked increase in the first quarter of the twentieth century (see Figure 
3). The fact that there has been a general improvement of early life circumstances over this same 
period further supports the hypothesis that height captures something of early life experience 
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relevant to later dementia risk, particularly in the light of recent studies suggesting that the 
prevalence29 of dementia might have decreased in recent years. 
 
Given the large sample size of the present study the smaller effect identified in women is unlikely 
to be explained by statistical instability. One possibility is that physical stature in women is less 
sensitive to living conditions. That diminishing secular increases in female height have been 
observed in recent years provides some support for this.19  
Comparison with other literature 
The published literature on the association between stature and dementia risk is detailed in Table 
3. The present study is the first examining the association between stature and dementia 
mortality. However, for comparison, research reporting on the association with clinical dementia 
will be discussed here. In a Medicare study of the association between knee height and arm span 
and dementia in four areas of the USA, 480 participants developed dementia over a mean 5.4 
year follow up.12 Both measures of shorter stature were associated with a higher risk of dementia 
in women, but only arm span was associated with dementia risk in men. A study in Israel, only 
including men, demonstrated an odds ratio of dementia (309 cases) comparing the tallest and 
shortest height quartiles of 0.51 (0.35-0.74) after adjusting for age, socioeconomic status, and 
region of birth.11 A study of Japanese Americans in Washington, USA, as part of the Ni-Hon-Sea 
Project – mainly focusing on head circumference – similarly commented that individuals 
developing dementia (59 incident cases) were shorter than those who did not go on to develop 
the condition. However this was not examined in detail.30  
 
Cross-sectional studies also add to the evidence for a link between height and dementia. A study 
of an older Korean population (N = 746, 110 dementia cases) found an association between 
shorter leg length and demispan and dementia after adjusting for age and education.31 When 
examining men and women separately their results were only statistically significant in women 
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but since only 41% of the sample were men, this might be a result of reduced power. Another 
Korean study (N=235; 46 dementia cases) found an association between decreased height and 
increased dementia risk (age- and sex-adjusted HR per cm decrease; 95%CI: 1.09; 1.05-1.14) 
which was attenuated with further adjustment for education, smoking, alcohol, pulse pressure, 
hypertension, and type 2 diabetes mellitus (1.03; 0.97-1.11).26 The HARMONY study of Swedish 
Twins conducted a case-control analysis of 310 people with dementia and 3063 controls.32 They 
found that being more than one standard deviation below the sex-specific mean in height was 
associated with an odds ratio of dementia of 1.57 (95%CI 1.11-2.22). A case-control study from 
the USA found a lower risk of Alzheimer’s disease in women, adjusted for age and education, 
but not men. 33 However when they stratified by APOE 4 status they only found this 
association in women without that allele (OR 0.88, 95%CI 0.80-0.97). A further Korean study 
found an association, only in women, between leg length and Alzheimer’s disease, after 
adjustment for age, rural residence in childhood and education.34 
 
There is growing evidence – from studies of variable quality and statistical power – that shorter 
body stature, measured in a variety of ways, is associated with an increased risk of cognitive 
decline and dementia in men and women. A number of studies have reported a dose-response 
association11, 12, 33, 35 but the majority have treated height as a continuous measure without 
demonstrating a linear relationship.26, 30, 31, 34, 36, 37 In the present study we were able to demonstrate 
a statistically significant, dose-response association between decreasing height and dementia 
death.  
 
One prospective study12 and two cross-sectional studies31, 34 showed a stronger association 
between height and dementia in women than in men. In the present study we found the 
converse. It is possible that this disagreement relates to power or to the different outcomes: the 
studies referred to above used a clinical diagnosis of dementia as their outcome, as opposed to 
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dementia-related death used in the current study. Details of dementia incidence were not 
available for our included cohort studies. We are not aware of any studies directly comparing risk 
factors for dementia incidence and dementia-related mortality. 
 
Limitations 
Our large sample was representative of the general population in the UK and was well-
characterised in terms of baseline characteristics. This provided sufficient power to allow gender-
specific analyses and allowed us to explore the role of a series of explanatory factors. Crucially, 
this study is well characterised for socioeconomic status (educational attainment and 
occupational social class) which is a key confounding variable given its association with dementia 
and height. 
 
This notwithstanding, the data also have their limitations. The number of dementia-related 
deaths in this study is likely to have been affected by the unavoidable problems of under-
diagnosis of dementia in the community,38 under-recording of dementia on death certificates, 
and diagnoses being inaccurately coded. Non-recording of dementia on death certificates has 
been highlighted as an important issue but this seems to be improving. A recent study identified 
that 71.5% of a clinic sample diagnosed with probable Alzheimer disease had dementia correctly 
recorded on their death certificate.39 There was no association in that sample between correct 
dementia certification and area deprivation or premorbid IQ estimated by the National Adult 
Reading Test (unpublished results available on request), suggesting that individuals reported as 
having dementia on their death certificate are representative of the population of people with 
diagnosed dementia in the community, at least in terms of intelligence and level of deprivation. 
 
Future research directions 
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Ideally, a long-term longitudinal study with adult height and relevant covariates measured in early 
life could be analysed over decades of follow up to investigate this association in more detail, 
including information on parental height in order to take genetic determinants of height into 
account. In the absence of such a study, a more detailed investigation of just what it is that 
height is capturing that is associated with later dementia risk to allow more accurate forecasts of 
dementia incidence to be calculated. 
 
Conclusion 
We have demonstrated a dose-response association between height and later dementia death 
which was robust to adjustment for a series of covariates. We hypothesise that the mechanism 
driving this association may be early life circumstances and thus add to the growing evidence for 
the role of pre-adult factors in later dementia risk. Furthermore, public health policies should 
continue on a broad front, including pre-school education, breakfast clubs, improved parenting 
schemes, and vaccination programmes. 
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FIGURE 1. Flow chart of participants from initial pooled sample through to analytic sample 
showing subsequent mortality: individual participant meta-analysis of eighteen cohort studies 
from the Health Survey for England and the Scottish Health Survey (N = 181,800) 
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FIGURE 2. Number of participants, total mortality and deaths from dementia by year. Also 
shown are age- and sex-adjusted hazard ratios with 95% confidence intervals of dementia death 
per standard deviation lower height by survey year for men (top) and women (bottom): 
individual participant meta-analysis of eighteen cohort studies from the Health Survey for 
England and the Scottish Health Survey (N = 181,800) 
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FIGURE 3. Scatterplot showing the secular trend (with 95% confidence interval) in height by birth year: individual participant meta-analysis of 
eighteen cohort studies from the Health Survey for England and the Scottish Health Survey (N = 181,800) 
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TABLE 1. Baseline characteristics of study members according to height quartile: individual 
participant meta-analysis of eighteen cohort studies from the Health Survey for England and the 
Scottish Health Survey (N = 181,800) 
 
Height1,2  
Q1 
(shortest) 
Q2 Q3 Q4 Total N3 
MEN      
N 20398 20890 20667 20376 82333 
Age [mean (SD)] 53.6 (18.8) 47.4 (17.6) 43.5 (16.7) 39.5 (15.0) 82333 
Non-manual social class (%) 38.6 45.5 51.1 56.6 79251 
Left school >16 years (%) 51.9 64.6 73.4 81.9 82290 
White British (%) 85.3 90.4 92.8 94.7 82333 
Body mass index [mean (SD)] 26.9 (4.4) 26.9 (4.2) 26.6 (4.2) 26.2 (4.0) 80281 
Never smoker (%) 38.8 41.5 44.5 48.1 81972 
Longstanding illness (%) 50.6 44.4 38.9 36.8 82314 
Systolic blood pressure [mean (SD)] 137.9 (19.8) 135.1 (17.2) 133.6 (15.8) 132.4 (14.5) 53255 
Serum cholesterol [mean (SD)] 5.7 (1.2) 5.7 (1.2) 5.5 (1.1) 5.4 (1.1) 27017 
WOMEN      
N 24443 25266 24971 24787 99467 
Age (mean [SD]) 54.2 (19.6) 47.2 (17.6) 43.4 (16.6) 39.3 (14.8) 99467 
Non-manual social class (%) 54.8 62.5 66.8 71.5 92695 
Left school >16 years (%) 51.2 64.7 72.6 82.3 99410 
White British (%) 85.8 90.9 93.0 94.5 99467 
Body mass index [mean (SD)] 27.4 (5.6) 26.8 (5.3) 26.2 (5.2) 25.6 (4.9) 94147 
Never smoker (%) 57.0 53.7 52.1 52.0 99130 
Longstanding illness (%) 51.3 43.4 40.5 36.1 99450 
Systolic blood pressure [mean (SD)] 135.4 (23.7) 130.4 (20.5) 127.1 (18.7) 124.7 (16.3) 63874 
Serum cholesterol [mean (SD)] 5.9 (1.3) 5.8 (1.2) 5.6 (1.2) 5.4 (1.1) 31519 
 
1 Mean height and its SD across the studies were 174.4±7.3 cm in men and 161.0±6.8 cm in 
women 
2 Sex-specific height quartiles were calculated using the following cut-points: Men 179·3cm, 
174·4cm, 169·6cm; Women 165·5cm, 161·1cm, 156·5cm 
3 Total number of participants with complete data for each variable 
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TABLE 2. Hazard ratios (95% confidence intervals) for the association between height quartile and dementia-
related death: individual participant meta-analysis of eighteen cohort studies from the Health Survey for England 
and the Scottish Health Survey (N = 181,800) 
 
Dementia 
deaths 
N 
Q41 
(tallest) 
Q3 Q2 Q1 
Per SD 
disadvantage2 
Ptrend 
MEN         
Age-adjusted 
(basic model) 
426 82333 
1 
(Ref.) 
1.27 
(0.75, 2.16) 
1.32 
(0.80, 2.17) 
1.67 
(1.05, 2.67) 
1.26 
(1.14, 1.40) 
<0.001 
+ Social class 425 79251 1 
1.22 
(0.72, 2.09) 
1.23 
(0.74, 2.03) 
1.52 
(0.95, 2.45) 
1.21 
(1.09, 1.34) 
<0.001 
+ Educational attainment 425 82290 1 
1.20 
(0.71, 2.05) 
1.25 
(0.76, 2.06) 
1.56 
(0.97, 2.50) 
1.24 
(1.11, 1.37) 
<0.001 
+ Ethnic group 426 82333 1 
1.29 
(0.76, 2.20) 
1.34 
(0.81, 2.22) 
1.73 
(1.08, 2.77) 
1.27 
(1.14, 1.41) 
<0.001 
+ Body mass index 413 80281 1 
1.24 
(0.73, 2.13) 
1.30 
(0.79, 2.16) 
1.70 
(1.06, 2.72) 
1.29 
(1.16, 1.44) 
<0.001 
+ Smoking status 426 81972 1 
1.25 
(0.71, 2.13) 
1.28 
(0.77, 2.11) 
1.59 
(0.99, 2.55) 
1.25 
(1.13, 1.39) 
<0.001 
+ Longstanding illness 426 82314 1 
1.26 
(0.74, 2.15) 
1.30 
(0.79, 2.15) 
1.68 
(1.05, 2.68) 
1.26 
(1.14, 1.40) 
<0.001 
+ Systolic blood pressure3 275 49030 1 
1.06 
(0.51, 2.19) 
1.22 
(0.60, 2.49) 
1.42 
(0.76, 2.67) 
1.30 
(1.14, 1.49) 
<0.001 
+ Serum cholesterol3 130 23911 1 
0.59 
(0.22, 1.59) 
1.03 
(0.26, 4.01) 
1.11 
(0.50, 2.46) 
1.28 
(1.03, 1.58) 
0.025 
Multivariable-adjusted4 411 76927 1 
1.15 
(0.67, 1.98) 
1.18 
(0.71, 1.96) 
1.50 
(0.93, 2.43) 
1.24 
(1.11, 1.39) 
<0.001 
Early deaths excluded 
(multivariable adjusted)4,5 
310 65455 1 
1.15 
(0.64, 2.07) 
1.36 
(0.77, 2.40) 
1.44 
(0.85, 2.45) 
1.27 
(1.12, 1.45) 
<0.001 
Non-missing sample 
(Age-adjusted) 
411 76927 1 
1.20 
(0.70, 2.05) 
1.26 
(0.76, 2.08) 
1.65 
(1.03, 2.63) 
1.27 
(1.14, 1.41) 
<0.001 
WOMEN         
Age-adjusted 
(basic model) 
667 99467 
1 
(Ref.) 
1.40 
(0.90, 2.19) 
1.04 
(0.66, 1.62) 
1.22 
(0.76, 1.97) 
1.10 
(1.01, 1.19) 
0.031 
+ Social class 617 86994 1 
1.37 
(0.87, 2.16) 
0.96 
(0.59, 1.57) 
1.19 
(0.73, 1.95) 
1.11 
(1.01, 1.19) 
0.026 
+ Educational attainment 667 99410 1 
1.33 
(0.85, 2.08) 
0.96 
(0.62, 1.50) 
1.11 
(0.70, 1.77) 
1.07 
(0.98, 1.16) 
0.143 
+ Ethnic group 667 99467 1 
1.40 
(0.90, 2.19) 
1.04 
(0.66, 1.64) 
1.25 
(0.78, 2.00) 
1.11 
(1.02, 1.20) 
0.018 
+ Body mass index 651 94147 1 
1.56 
(0.98, 2.48) 
1.19 
(0.75, 1.90) 
1.49 
(0.91, 2.44) 
1.15 
(1.05, 1.25) 
0.002 
+ Smoking status 666 99130 1 
1.41 
(0.90, 2.20) 
1.04 
(0.67, 1.62) 
1.23 
(0.78, 1.96) 
1.10 
(1.01, 1.19) 
0.032 
+ Longstanding illness 667 99450 1 
1.43 
(0.92, 2.24) 
1.05 
(0.68, 1.63) 
1.25 
(0.78, 2.00) 
1.10 
(1.01, 1.19) 
0.033 
+ Systolic blood pressure3 431 62684 1 
1.55 
(0.87, 2.78) 
1.10 
(0.63, 1.90) 
1.41 
(0.85, 2.34) 
1.09 
(0.98, 1.21) 
0.118 
+ Serum cholesterol3 195 27696 1 
1.67 
(0.75, 3.74) 
1.44 
(0.66, 3.16) 
1.60 
(0.75, 3.39) 
1.05 
(0.90, 1.22) 
0.542 
Multivariable-adjusted4 601 821156 1 
1.48 
(0.92, 2.39) 
1.06 
(0.64, 1.74) 
1.35 
(0.80, 2.28) 
1.13 
(1.03, 1.24) 
0.011 
Early deaths excluded 
(multivariable adjusted)4,5 
495 74221 1 
1.39 
(0.81, 2.39) 
0.95 
(0.49, 1.85) 
1.05 
(0.45, 2.49) 
1.10 
(0.99, 1.22) 
0.063 
Non-missing sample 
(Age-adjusted) 
601 821156 1 
1.50 
(0.93, 2.42) 
1.08 
(0.63, 1.85) 
1.38 
(0.79, 2.39) 
1.14 
(1.05, 1.25) 
0.003 
 
1 Sex-specific height quartiles were calculated using the following cut-points: Men 179.3cm, 174.4cm, 169.6cm; Women 165.5cm, 161.1cm, 
156.5cm. 
2 Calculated using sex-specific standard deviations: Men 7.3cm; Women 6.8cm. 
3 Data were only available for a subsample and therefore these covariates are not included in the multivariable model. 
4 Model adjusted for age, occupational social class, educational attainment, self-reported ethnic group, body mass index, smoking status, 
self-reported longstanding illness, and year of birth. 
5 Deaths occurring within the first five years of follow up dropped. No events occurred in HSE 2006-2008 so these surveys were excluded. 
6 No events occurred in HSE 2008 so this survey was excluded from this model
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TABLE 3. Articles examining the association between height (body height, knee height, or leg length) and dementia: individual participant meta-analysis of eighteen 
cohort studies from the Health Survey for England and the Scottish Health Survey (N = 181,800) 
 
Article Design Population Exposure Outcome Methods Main results 
Huang et al. 
(2008)12 
Prospective 
(average 5.4 years 
of follow-up) 
2798 men and women in the 
USA aged ≥65 years 
Knee height and arm span 
measured at baseline – 
continuous measures and 
quartiles 
Two-stage screening culminating 
in clinical diagnosis of dementia 
(N=412) 
Cox proportional 
hazards models 
Age-, race-, and APOE status-adjusted HR per cm increase in knee height: Men 
0.93 (95%CI 0.81, 1.07); Women 0.84 (0.74, 0.96) 
HR additionally adjusted for education, income and self-reported health: Men 
0.95 (0.83, 1.10); Women 0.88 (0.77, 1.00) 
Beeri et al. 
(2005)11 
Prospective (over 
three decades of 
follow up) 
1892 men living in Israel aged 
76-95 years 
Height measured in 1963 as part 
of the Israeli Ischemic Heart 
Disease Project – quartiles 
Two-phase screening culminating 
in clinical diagnosis of dementia 
(N=309) 
Logistic 
regression 
OR (95%CI) of dementia adjusted for age, socioeconomic status, and 
geographical area of birth in tallest vs shortest quartile: 0.51 (0.35, 0.74). 
Approximately similar results for AD and vascular dementia. 
Borenstein 
Graves et al. 
(2001)30 
Prospective 
(average 3.8 years 
of follow-up) 
1869 Japanese American men 
and women aged ≥65 years 
Height measured at baseline – 
continuous 
Two-phase screening culminating 
in clinical diagnosis of AD 
(N=59) 
t-test Mean height (SD) in incident cases of probable AD 1.5m (0.1) vs other 
participants 1.6m (0.09), p=0.009. 
N.B. The main exposure examined in the paper was head circumference. 
Kim et al. 
(2008)34  
Cross-sectional 916 Korean men and women 
aged ≥65 years 
Leg length measured at initial 
study visit – continuous measure 
Clinical diagnosis of dementia 
(N=128) 
Logistic 
regression 
Age-adjusted OR per 7cm decrease in leg length, 95%CI: Men 1.17 (0.87, 1.56); 
Women 1.51 (1.19, 1.92). 
OR adjusted for age, heart disease, hypertension, and diabetes: Men 0.99 (0.82, 
1.38); Women 1.34 (1.02, 1.75). 
Petot et al. 
(2007)33 
Cross-sectional Men and women in the USA 
aged ≥60 years (341 controls, 
239 cases) 
Height measured at the time of 
the study – quartiles 
Clinical diagnosis (both cases and 
controls were assessed) 
Case-control OR (95%CI) shortest vs tallest quartile: Men 0.41 (0.2, 0.9); Women 0.38 (0.4, 
1.5). 
Gatz et al. 
(2006)32 
Cross-sectional Swedish twins aged ≥65 years 
and alive in 1998 (HARMONY 
study; 3053 controls, 310 cases) 
Height reported on mailed 
questionnaire – dichotomous 
variable  
Two-phase screening culminating 
in clinical diagnosis of dementia 
Case-control  Age- and sex-adjusted OR (95%CI) for dementia in short height group (>1SD 
shorter than mean for their sex) vs others: 1.57 (1.11, 2.22). 
OR (95%CI) adjusted for age, sex, education, mentally stimulating activities, 
physical exercise, oral disease, and parents’ social class: 1.49 (1.04, 2.12). 
Monozygotic co-twin control analyses using height as a dichotomous variable: OR 
for the short height group (95%CI): 1.75 (0.51, 5.98). Similar analyses treating 
height as an ordinal variable (comparing exposure status within twin pairs) OR for 
the short height group (95%CI): 1.31 (0.85, 2.04). 
Jeong et al. 
(2005)26 
Cross-sectional 235 Korean men and women 
aged ≥65 years 
Arm span and height measured 
at the time of the study – 
continuous measure 
Clinical diagnosis of dementia 
(N=46; stated as 19.6%) and 
assessment scales (MMSE, 
IADL, and SDQ) 
Linear and 
logistic 
regression 
Arm span and height were associated with MMSE and IADL scores but not 
SDQ. 
Age- and sex- adjusted OR (95%CI) for dementia per cm decrease in height: 
1.09 (1.05, 1.14). 
OR (95%CI) adjusted for age, sex, education, smoking, alcohol consumption, 
pulse pressure, hypertension, and type 2 diabetes mellitus: 1.03 (0.97, 1.11). 
Kim et al. 
(2003)31 
Cross-sectional 746 Korean men and women 
aged ≥65 years 
Arm span, leg length, and sitting 
height measured at the time of 
the study – continuous measure 
Two-phase screening culminating 
in clinical diagnosis of dementia 
(N=110) 
Logistic 
regression 
OR (95%CI) for dementia adjusted for age and education per 5cm decrease in 
leg length: Men 1.03 (0.64, 1.65); Women 1.80 (1.29, 2.51). 
AD = Alzheimer’s disease; CI = confidence interval; HR = hazard ratio; IADL = instrumental activities of daily living scale; MMSE = Mini mental state examination; OR = odds ratio; SDQ = Samsung dementia questionnaire 
